Next Article in Journal
Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure
Next Article in Special Issue
Biocompatible PLGA-Mesoporous Silicon Microspheres for the Controlled Release of BMP-2 for Bone Augmentation
Previous Article in Journal
Both IgM and IgG Antibodies against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice
Previous Article in Special Issue
Risperidone-Loaded PLGA–Lipid Particles with Improved Release Kinetics: Manufacturing and Detailed Characterization by Electron Microscopy and Nano-CT
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(1), 16; https://doi.org/10.3390/pharmaceutics12010016
Action Date Notes Link
article xml file uploaded 21 December 2019 12:34 CET Original file -
article xml uploaded. 21 December 2019 12:34 CET Update https://www.mdpi.com/1999-4923/12/1/16/xml
article pdf uploaded. 21 December 2019 12:34 CET Version of Record https://www.mdpi.com/1999-4923/12/1/16/pdf
article supplementary file uploaded. 21 December 2019 12:34 CET - https://www.mdpi.com/1999-4923/12/1/16#supplementary
article html file updated 21 December 2019 12:36 CET Original file -
article html file updated 5 February 2020 12:25 CET Update -
article html file updated 14 February 2020 20:51 CET Update -
article html file updated 19 July 2022 21:04 CEST Update https://www.mdpi.com/1999-4923/12/1/16/html
Back to TopTop